Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Sucampo Pharmaceuticals Inc

+ Add to Watchlist


18.0600 USD 0.5100 2.91%

As of 20:10:00 ET on 05/06/2015.

Company Profile for Sucampo Pharmaceuticals Inc (SCMP)

Sucampo Pharmaceuticals, Inc. researches and develops drugs based on protones, which are derived from functional fatty acids. The Company produces a prescription drug for the treatment of chronic idiopathic constipation.

Contact Information

Sucampo Pharmaceuticals Inc

4520 East-West Highway
Suite 300
Bethesda, MD 20814
United States
Phone: 1-301-961-3400
Fax: 01-301-961-3440

Key Executives for Sucampo Pharmaceuticals Inc (SCMP)

Peter GreenleafChief Executive OfficerAndrew P SmithChief Financial Officer
Peter A KienerChief Scientific OfficerThomas J KnappExec VP/Chief Legal Ofcr/Secy
Matthias AlderExec VP:Bus Dev & LicensingSilvia TaylorSenior VP:Investor Relations
Steven CaffeSenior VP:Regulatory AffairsStanley G MieleSenior VP:Sales & Marketing
Kathryn De Santis "Kate"VP:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil